• This record comes from PubMed

Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity

. 2012 May ; 44 (5) : 738-47. [epub] 20120128

Language English Country Netherlands Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Malignant gliomas exhibit abnormal expression of proteolytic enzymes that may participate in the uncontrolled cell proliferation and aberrant interactions with the brain extracellular matrix. The multifunctional membrane bound serine aminopeptidase dipeptidyl peptidase (DPP)-IV has been linked to the development and progression of several malignancies, possibly both through the enzymatic and nonenzymatic mechanisms. In this report we demonstrate the expression of DPP-IV and homologous proteases fibroblast activation protein, DPP8 and DPP9 in primary cell cultures derived from high-grade gliomas, and show that the DPP-IV-like enzymatic activity is negatively associated with their in vitro growth. More importantly, the DPP-IV positive subpopulation isolated from the primary cell cultures using immunomagnetic separation exhibited slower proliferation. Forced expression of the wild as well as the enzymatically inactive mutant DPP-IV in glioma cell lines resulted in their reduced growth, migration and adhesion in vitro, as well as suppressed glioma growth in an orthotopic xenotransplantation mouse model. Microarray analysis of glioma cells with forced DPP-IV expression revealed differential expression of several candidate genes not linked to the tumor suppressive effects of DPP-IV in previous studies. Gene set enrichment analysis of the differentially expressed genes showed overrepresentation of gene ontology terms associated with cell proliferation, cell adhesion and migration. In conclusion, our data show that DPP-IV may interfere with several aspects of the malignant phenotype of glioma cells in great part independent of its enzymatic activity.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

Microtubule-associated NAV3 regulates invasive phenotypes in glioblastoma cells

. 2025 Jan ; 35 (1) : e13294. [epub] 20240803

Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA

. 2024 Sep 01 ; 141 (3) : 602-613. [epub] 20240329

New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity

. 2022 Aug 17 ; 14 (8) : . [epub] 20220817

Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?

. 2022 Apr 21 ; 14 (9) : . [epub] 20220421

Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis

. 2021 Jul 01 ; 13 (13) : . [epub] 20210701

Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival

. 2018 Feb 12 ; 8 (1) : 2836. [epub] 20180212

Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma

. 2016 Oct ; 37 (10) : 13961-13971. [epub] 20160804

Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro

. 2015 Aug ; 36 (8) : 5873-9. [epub] 20150225

Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets

. 2015 May ; 143 (5) : 497-504. [epub] 20141102

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...